1000 MYLAN BOULEVARD, CANONSBURG, PA
2026 Annual Meeting Results - Director Elections and Compensation Approved
Reports First-Quarter 2026 Financial Results
Announces Chief Financial Officer Transition
Annual Report to Security Holders
Reports Fourth-Quarter and Full-Year 2025 Financial Results
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Announces Agreement to Monetize its Equity Stake in Biocon Biologics Limited
Amended material disclosure
Q1
FY 2024
Q3
Q2
Amended Annual Report
FY 2023
S-3ASR
Registration Statement for Securities to be Offered to Employees
Tender Offer Statement by Third Party
Tender Offer Statement by Issuer
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Tender Offer Statement by Third Party